1254239

AstraZeneca Pharmaceuticals LP — FEI 1000198729

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
October 25, 2024
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Gaithersburg, MD (United States)

Additional Details

Sponsor, Contract Research Organization